Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Sirna Therapeutics Inc -- Ignore unavailable to you. Want to Upgrade?

To: nigel bates who wrote (549)	6/3/2003 4:00:59 AM
From: Thomas	Respond to of 562

Hi Nigel, Ahh, I think yes would have to be the answer to that question. How much longer can the fumes carry RNAI? That is a good question. I would be interested to know what institutions still hold RNAI, since with such a micro float, any meaningful buyer or seller will move the stock price substantially. Yesterday's wild runup seems to be on general market/biotech enthusiasm. Since there are no siRNA trials ongoing at Sirna (at least as far as I know), and since the existing ribozyme trials were/are disappointing, there cannot be a 5x difference between what the company is worth now and what it was worth a month ago. FWIW. Cheers, Thomas